Brain Cancer Global Clinical Trials Review, H1, 2014
Brain Cancer Global Clinical Trials Review, H1, 2014
Summary
GlobalDa...
f. Hoffmann-la Roche Ltd. 43
clinical Trial Overview Of F. Hoffmann-la Roche Ltd. 43
glaxosmithkline Plc 45
clinical Trial...
Upcoming SlideShare
Loading in …5
×

Brain Cancer Global Clinical Trials Market Review, H1, 2014: New Report

248 views
169 views

Published on

Brain Cancer Global Clinical Trials Market Review, H1, 2014 @ http://www.researchmoz.us/brain-cancer-global-clinical-trials-review-h1-2014-report.html

This report provides elemental information and data relating to the clinical trials on Brain Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Brain Cancer.

Published in: Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
248
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Brain Cancer Global Clinical Trials Market Review, H1, 2014: New Report

  1. 1. Brain Cancer Global Clinical Trials Review, H1, 2014 Brain Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, Brain Cancer Global Clinical Trials Review, H1, 2014" provides data on the Brain Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Brain Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Brain Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies Table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 5 introduction 6 brain Cancer 6 report Guidance 6 clinical Trials By Region 7 clinical Trials And Average Enrollment By Country 8 top Five Countries Contributing To Clinical Trials In Asia-pacific 10 top Five Countries Contributing To Clinical Trials In Europe 11 top Countries Contributing To Clinical Trials In North America 12 top Five Countries Contributing To Clinical Trials In Middle East And Africa 13 top Five Countries Contributing To Clinical Trials In Central And South America 14 clinical Trials By G7 Countries: Proportion Of Brain Cancer To Oncology Clinical Trials 15 clinical Trials By Phase In G7 Countries 16 clinical Trials In G7 Countries By Trial Status 17 clinical Trials By E7 Countries: Proportion Of Brain Cancer To Oncology Clinical Trials 18 clinical Trials By Phase In E7 Countries 19 clinical Trials In E7 Countries By Trial Status 20 clinical Trials By Phase 21 in Progress Trials By Phase 22 clinical Trials By Trial Status 23 clinical Trials By End Point Status 24 unaccomplished Trials Of Brain Cancer 25 subjects Recruited Over A Period Of Time 34 clinical Trials By Sponsor Type 35 prominent Sponsors 36 top Companies Participating In Brain Cancer Therapeutics Clinical Trials 37 prominent Drugs 38 latest Clinical Trials News On Brain Cancer 39 jan 07, 2014: E-therapeutics Provides Update On Ets2101 Phase I Trial In Brain Cancer 39 dec 16, 2013: Positive Phase 2 Results From Agenus Brain Cancer Vaccine Published In Neuro-oncology 39 nov 25, 2013: Newgen Therapeutics Reports Potent Anticancer Activity For Targeted Brain Cancer Drug, Nt-113 40 oct 21, 2013: Angiochem Initiates Phase 2 Clinical Study For Lead Drug Candidate, Ang1005, In Primary Brain Cancer 41 jun 11, 2013: Critical Outcome Technologies Announces Positive Preclinical Results Of Cancer Drug Candidiate Coti-2 Against P53 Gene Mutations 41 clinical Trial Profiles 43 clinical Trial Overview Of Top Companies 43 Brain Cancer Global Clinical Trials Review, H1, 2014
  2. 2. f. Hoffmann-la Roche Ltd. 43 clinical Trial Overview Of F. Hoffmann-la Roche Ltd. 43 glaxosmithkline Plc 45 clinical Trial Overview Of Glaxosmithkline Plc 45 novartis Ag 47 clinical Trial Overview Of Novartis Ag 47 merck & Co., Inc. 48 clinical Trial Overview Of Merck & Co., Inc. 48 pfizer Inc. 49 clinical Trial Overview Of Pfizer Inc. 49 sanofi 50 clinical Trial Overview Of Sanofi 50 astrazeneca Plc 51 clinical Trial Overview Of Astrazeneca Plc 51 bayer Ag 52 clinical Trial Overview Of Bayer Ag 52 burzynski Research Institute, Inc. 53 clinical Trial Overview Of Burzynski Research Institute, Inc. 53 angiochem Inc. 54 clinical Trial Overview Of Angiochem Inc. 54 clinical Trial Overview Of Top Institutes / Government 55 national Cancer Institute 55 clinical Trial Overview Of National Cancer Institute 55 the University Of Texas M. D. Anderson Cancer Center 66 clinical Trial Overview Of The University Of Texas M. D. Anderson Cancer Center 66 memorial Sloan Kettering Cancer Center 68 clinical Trial Overview Of Memorial Sloan Kettering Cancer Center 68 duke University 71 clinical Trial Overview Of Duke University 71 children's Oncology Group 73 clinical Trial Overview Of Children's Oncology Group 73 european Organization For Research And Treatment Of Cancer 75 clinical Trial Overview Of European Organization For Research And Treatment Of Cancer 75 sidney Kimmel Comprehensive Cancer Center 77 clinical Trial Overview Of Sidney Kimmel Comprehensive Cancer Center 77 pediatric Brain Tumor Consortium 78 clinical Trial Overview Of Pediatric Brain Tumor Consortium 78 stanford University 79 clinical Trial Overview Of Stanford University 79 five Key Clinical Profiles 80 appendix 119 abbreviations 119 definitions 119 research Methodology 120 secondary Research 120 about Globaldata 121 contact Us 121 disclaimer 121 source 122 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Brain Cancer Global Clinical Trials Review, H1, 2014

×